Home
Scholarly Works
A phase I/II clinical trial of veliparib (ABT-888)...
Conference

A phase I/II clinical trial of veliparib (ABT-888) and radiation followed by maintenance therapy with veliparib and temozolomide in patients with newly diagnosed diffuse intrinsic pontine glioma (DIPG): A Pediatric Brain Tumor Consortium Interim Report of Phase I Study.

Authors

Baxter PA; Su JM; Li X-N; Onar-Thomas A; Billups CA; Thompson PA; Goldman S; Gururangan S; Young-Poussaint T; McKeegan EM

Volume

33

Publisher

AMER SOC CLINICAL ONCOLOGY

Publication Date

May 20, 2015

Name of conference

51st Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer

Conference place

Chicago, IL

Conference start date

May 29, 2015

Conference end date

June 2, 2015

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

15

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team